Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Table 1.

Characteristics of DLBCL patients.

More »

Table 1 Expand

Fig 1.

Immunohistochemical analysis of MYC, BCL2, and Ki-67 expression in DLBCL (A) MYC protein positive (X40); (B) MYC protein negative (X40); (C) BCL2 protein positive (X40); (D) BCL2 protein negative (X40); (E) High Ki-67 expression (X40); (F) Low Ki-67 expression (X40).

More »

Fig 1 Expand

Table 2.

Comparison of protein expression and clinical appearance.

More »

Table 2 Expand

Fig 2.

Overall survival and progression-free survival of MYC, BCL2, and Ki-67 expression in DLBCL by Kaplan-Meier analysis.

More »

Fig 2 Expand

Fig 3.

Overall survival and progression-free survival of age, IPI risk score, and ECOG score in DLBCL by Kaplan-Meier analysis.

More »

Fig 3 Expand

Fig 4.

Overall survival of double expressor in DLBCL by Kaplan-Meier analysis.

More »

Fig 4 Expand

Table 3.

Univariable and multivariable analysis for progression-free survival.

More »

Table 3 Expand

Table 4.

Univariable and multivariable analysis for overall survival.

More »

Table 4 Expand